DOXAZOSIN - doxazosin tablet 
Zydus Lifesciences Limited

----------

DOXAZOSIN TABLETS

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70771-1112-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 1 mg

Rx only

100 Tablets

container label 1 mg - 100s count

NDC 70771-1113-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 2 mg

Rx only

100 Tablets

container label 2 mg- 100s count

NDC 70771-1114-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 4 mg

Rx only

100 Tablets

container label 4 mg - 100s count

NDC 70771-1115-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 8 mg

Rx only

100 Tablets

container label - 8 mg - 100s count
DOXAZOSIN 
doxazosin tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1112
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOXAZOSIN MESYLATE (UNII: 86P6PQK0MU) (DOXAZOSIN - UNII:NW1291F1W8) DOXAZOSIN1 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
Product Characteristics
ColorWHITE (WHITE TO OFF-WHITE) Score2 pieces
ShapeROUND (ROUND BICONVEX) Size7mm
FlavorImprint Code 783
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70771-1112-330 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
2NDC:70771-1112-1100 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
3NDC:70771-1112-01000 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
4NDC:70771-1112-410 in 1 CARTON08/31/2017
4NDC:70771-1112-210 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20871908/31/2017
DOXAZOSIN 
doxazosin tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1113
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOXAZOSIN MESYLATE (UNII: 86P6PQK0MU) (DOXAZOSIN - UNII:NW1291F1W8) DOXAZOSIN2 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
Product Characteristics
ColorPINK (LIGHT PINK TO PINK) Score2 pieces
ShapeROUND (ROUND BICONVEX) Size7mm
FlavorImprint Code 784
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70771-1113-330 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
2NDC:70771-1113-1100 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
3NDC:70771-1113-01000 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
4NDC:70771-1113-410 in 1 CARTON08/31/2017
4NDC:70771-1113-210 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20871908/31/2017
DOXAZOSIN 
doxazosin tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1114
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOXAZOSIN MESYLATE (UNII: 86P6PQK0MU) (DOXAZOSIN - UNII:NW1291F1W8) DOXAZOSIN4 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
Product Characteristics
ColorPINK (LIGHT PINK TO PINK) Score2 pieces
ShapeCAPSULE (CAPSULE, BICONVEX) Size12mm
FlavorImprint Code 785
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70771-1114-330 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
2NDC:70771-1114-1100 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
3NDC:70771-1114-01000 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
4NDC:70771-1114-410 in 1 CARTON08/31/2017
4NDC:70771-1114-210 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20871908/31/2017
DOXAZOSIN 
doxazosin tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1115
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOXAZOSIN MESYLATE (UNII: 86P6PQK0MU) (DOXAZOSIN - UNII:NW1291F1W8) DOXAZOSIN8 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
Product Characteristics
ColorPURPLE (LIGHT PURPLE TO PURPLE) Score2 pieces
ShapeROUND (ROUND BICONVEX) Size9mm
FlavorImprint Code 786
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70771-1115-330 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
2NDC:70771-1115-01000 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
3NDC:70771-1115-410 in 1 CARTON08/31/2017
3NDC:70771-1115-210 in 1 BLISTER PACK; Type 0: Not a Combination Product
4NDC:70771-1115-1100 in 1 BOTTLE; Type 0: Not a Combination Product08/31/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20871908/31/2017
Labeler - Zydus Lifesciences Limited (918596198)
Registrant - Zydus Lifesciences Limited (918596198)
Establishment
NameAddressID/FEIBusiness Operations
Zydus Lifesciences Limited863362789ANALYSIS(70771-1112, 70771-1113, 70771-1114, 70771-1115) , MANUFACTURE(70771-1112, 70771-1113, 70771-1114, 70771-1115)

Revised: 8/2022
Document Id: 48bd7791-467c-44e8-8c3a-fb1de8a4afa9
Set id: ac889877-133c-4448-af5a-d77b3cbfe878
Version: 4
Effective Time: 20220825
 
Zydus Lifesciences Limited